Haemonetics | HAE - Cost Of Sales


Haemonetics reported $136.58M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Cerus USD 23.42M 3.61M Dec/2024
Cooper Companies USD 393.8M 17M Mar/2026
Fresenius EUR 4.4B 111M Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
Haemonetics USD 136.58M 11.56M Jun/2026
ICU Medical USD 316.63M 7.37M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
Medtronic USD 3.8B 195M Mar/2026
Merit Medical Systems USD 203.68M 6.6M Jun/2026
Neogen USD 117.5M 5.3M Mar/2026
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD 407M 486.5M Jun/2026
ResMed USD 612.93M 61.26M Jun/2026
STAAR Surgical USD 23.81M 855K Jun/2026
Steris USD 808.6M 82.7M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
US Physical Therapy USD 169.99M 6.39M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026